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SUMMARY 
(1) Premenstrual mood changes such as depression, elation, anxiety, hostility and irrita- 
bility are a common cause of disability in women. (2) The nature of the disorder, the clinical 
dimensions, the incidence, the psychological and psychosocial theories are reviewed. (3) A 
long list of treatments recommended over the years is also reviewed and discussed, illustrat- 
ing the ambiguity and uncertainty in this area. (4) The relationship to other periodic functional 
conditions, especially manic-depressive illness is discussed with particular emphasis on 
predictive studies. (5) The psychoneuroendocrine mechanisms possibly involved in these pre- 
menstrual conditions are reexamined. A specific role for prolactin in the etiology of these 
premenstrual dysphoric states is suggested. 
INTRODUCTION 
THE RUBRIC 'premenstrual tension syndrome' (PTS) encompasses a vast array of symptoms, 
involving many organs and systems. Over the years many theories about its etiology have 
been proposed and many kinds of treatment have been attempted. We do not propose to 
review the PTS literature exhaustively since a number of excellent reviews have appeared 
recently (Janowsky, F a n n &  Davis, 1971; Cullberg, 1972; Tonks, 1975; Smith, 1975; 
Bardwick, 1976). The major issues can be stated in a concise way as follows: 
(1) Although the incidence estimates vary widely, many women do indeed develop a 
variety of physical, psychological and behavioral changes in the late luteal phase of the 
menstrual cycle (Dalton, 1964). 
(2) The clinical dimensions of this premenstrual syndrome have always been rather 
broad. Rees (1953) included the following symptoms: tension, irritability, anxiety, depressed 
mood, insomnia, fatigue, nausea or vomiting, headaches, dizziness, fluid retention, thirst, 
edema, breast enlargement and tenderness, pruritus, increased appetite and altered sexual 
drive. He also found an increased tendency for psychosomatic disorders such as asthma, 
migraine, rhinitis and angioneurotic edema to occur in the premenstruum. Dalton (1964) 
listed an equally wide range of symptoms and emphasized the major psychological symptoms 
of irritability, depression and lethargy. 
(3) In a large factor analytic study of the PTS, Moos (1969b) identified eight major 
clusters of symptoms, and proposed that the undifferentiated term 'premenstrual syndrome' 
might more appropriately be labelled 'the premenstrual syndromes'. The symptom clusters 
which he identified were termed: pain, concentration, behavioral change, autonomic 
reactions, water retention, negative affect and arousal. An eighth cluster of 'control' 
321 
322 MErR STEINER and BERNARD J. CARROLL 
symptoms was included to deal with the issue of nonspecific symptom-claiming. A number 
of distinct symptom profiles were identified. 
(4) The dysphoria or negative affect which occurs premenstrually has been variously 
described as anxiety, hostility, irritability and depression. None of the studies to date have 
detailed the phenomenology of premenstrual affective change in a way which makes 
comparison with primary affective disorders possible. As Smith (1975) puts it: "The 
phenomenology of premenstrual depression has not been studied with the rigor necessary 
to fit it accurately into the current classification of depression". 
(5) Premenstrual dysphoria can be distinguished from the condition of dysmenorrhoea 
(painful periods) (Coppen & Kessel, 1963; Dalton, 1964; Moos, 1969a). The two conditions 
may occur together, but they are not associated strongly and they correlate differently with 
neuroticism. Similarly, premenstrual edema is a clinical entity which is sometimes but by 
no means always associated with premenstrual dysphoria (see Smith, 1975; Moos, 1969a). 
(6) The incidence of significant premenstrual dysphoria is said to range from 25 to almost 
100 ~o, depending upon the methods used to obtain the information and on the operational 
definition of the syndrome (Coppen & Kessel, 1963; Brown-Parlee, 1973). 
(7) Various psychological and psychosocial theories about the premenstrual syndromes 
have been advanced. It appears that these factors account for only a minor part of the 
variance in most studies. For example, Rees (1953) observed a correlation between pre- 
menstrual tension and neurotic predisposition, but noted that some very neurotic women 
had no symptoms of PTS, while others who improved psychologically with psychotherapy 
did not necessarily improve in their premenstrual tension. He concluded that physiological 
as well as psychological factors were important. Similar findings were published more 
recently by James & Pollitt (1974). 
(8) There are many reports dealing with the exacerbation of psychiatric illness during the 
premenstrual period. These are discussed by Smith (1975), Glass, Heninger, Lansky & 
Talan (1971), Janowsky, Gorney, Castelnuovo-Tedesco & Stone (1969) and Wetzel & 
McClure (1972). Suicidal behavior, psychiatric hospitalization and psychiatric emergencies 
are all said to be increased above expected levels during the premenstruum. Premenstrual 
epilepsy is another well-known condition (Laidlaw, 1956; Dalton, 1964). Other reports of, 
miscellaneous behavior disorders in the premenstruum, such as hyperactive, aggressive 
violent or criminal behavior are less well substantiated (see Brown-Parlee, 1973; Smith, 
1975). 
(9) A number of authors have addressed the obvious possibility that episodic mood 
shifts which occur premenstrually might be related to manic-depressive illness. McClure, 
Reich & Wetzel (1971) suggested such a connection after noting the existence of bipolar 
symptoms in some women with premenstrual mood change. In a later study from this 
group, young college women with premenstrual mood change were seen with increased 
frequency for affective disorders in the Student Health Service over the next 4 yr (Wetzel, 
Reich, McClure & Wald, 1975). In this study, and in a related one from the St. Louis group 
(McClure et al., 1971) a small number of women was noted with premenstrual mood 
elevation; they were found to have personal and family histories of bipolar affective disorder. 
These reports tend to support the earlier claims of Kramp (1968) and of Williams & Weekes 
(1952). By contrast, no increased prevalence of PTS was found by Coppen (1965) in patients 
PREMENSTRUAL DYSPHORIA 323 
with diagnosed affective disorders, whereas he did find a high incidence in neurotic patients. 
This study has been criticized by several later workers (Smith, 1975; Wetzel et al., 1975) 
for methodological reasons. 
In a more recent study (Kashiwagi, McClure & Wetzel, 1976) a definitely increased 
prevalence of premenstrual mood change was found in women with primary affective 
disorder, compared with women diagnosed as suffering from hysteria or anxiety neurosis. 
The discrepancy between these findings and the report of Coppen (1965) may be attributed 
to (1) sampling differences or (2) more likely, the diagnostic criteria employed. 
Kashiwagi et al. (1976), following the model introduced by Feighner, Robins, Guze, 
Woodruff, Winokur & Muzon (1972) for psychiatric diagnosis, adopted a new set of 
criteria for the diagnosis of premenstrual affective syndrome. The women in this study were 
originally referred to a neurologic clinic with functional headache, 75 ~o were black and the 
criteria used included a mixture of physical and psychological symptoms. Diamond, 
Rubinstein, Dunner & Fieve (1976) compared women with previously diagnosed affective 
illness to a control group and found no difference with regard to somatic symptoms at 
menstruation. Dysphoric symptoms in relation to the menstrual cycle showed only a slight 
trend toward increased reporting by the affective group. There was a tendency observed for 
women to be hospitalized for depression during the late premenstrual phase of the cycle. 
Their interpretation of these findings is that women predisposed to affective disorders, but 
not suffering from a current episode, experience menstruation in much the same way that 
normal women do. On the other hand, patients in the middle of an episode may experience 
a premenstrual worsening of their current symptoms, so that hospital admission is often 
precipitated at that time. 
(10) The scientific status of much of the clinical lore associated with the concept of pre- 
menstrual tension has been subjected to searching critiques by Brown-Parlee (1973) and 
Smith (1975). Notwithstanding these reservations, the existence of the syndrome (or syn- 
dromes) is not doubted seriously, and it does appear to be a significant cause of distress for 
many women and their families. The description by Dalton (1971) is an arresting one: 
"In premenstrual depression the mood changes are short-lived, the depression lasting only 
a few days at a time with improvement, often abrupt, occurring during menstruation. But 
the depth of depression may be extreme, reaching suicide level, or a temporary psychosis 
may develop. The depression is accompanied by tension, irritability with aggression which 
may result in a battered baby or bruised husband, and lethargy, both mental and physical." 
BIOLOGICAL THEORIES OF PREMENSTRUAL DYSPHORIA 
1. Hormonal changes during the normal menstrual cycle 
The interactions of the hypothalamus, pituitary gland, ovary and adrenal cortex, together 
with the endometrium, are responsible for the cyclical regular and recurrent process of 
ovulation and menstruation. In response to a hypothalamic releasing factor, the anterior 
pituitary produces follicle-stimulating hormone (FSH) which stimulates the development of 
the ovarian follicles and causes constant estrogen secretion during this phase of the cycle. 
Estrogen secretion rises to a peak at mid cycle when, through a hypothalamic feedback 
mechanism, a surge of luteinizing hormone (LH) occurs together with a peak of FSH 
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Fio. 1. Mean serum prolactin, LH, estrogens, FSH and progesterone in 10 women with regular menstrual 
cycles, sampled between late morning and early afternoon. From Robyn et al. (1973) Reproduced by 
permission of Excerpta Medica Amsterdam, American Elsevier Publishing Company, Inc., New York. 
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release. Ovulation then occurs and the corpus luteum begins to secrete progesterone. This 
is termed the luteal phase of the cycle. If fertilization of the ovary has not occurred, then 
progesterone secretion begins to decrease about 6 days prior to menstruation. Estrogen 
secretion from the ovary also begins to fall at about the same time (Fig. 1). 
Prolactin. There has been considerable disagreement about the cyclic secretion of pro- 
lactin during the normal cycle. Robyn, Delvoye, Nokin, Vekemans, Badawi, Perez-Lopez 
& L'Hermite (1973) have reported that prolactin secretion rises to a mid-cycle peak together 
with plasma estrogen levels, drops temporarily after ovulation, and then increases again 
so that levels during the luteal phase are considerably higher than during the follicular 
phase. Figure 1 displays the monthly cycle of prolactin, LH, estrogens, FSH and pro- 
gesterone during the normal cycle. According to Robyn, plasma prolactin levels remain 
elevated during the late luteal phase at a time when estrogen and progesterone levels are 
dropping rapidly. Prolactin levels do not return to follicular phase levels until after the 
onset of menstruation (Fig. 1). Several years ago other workers (e.g. McNeiUy, Evans & 
Chard, 1973) were in disagreement with this report from Robyn's group and maintained 
that plasma prolactin levels showed essentially no cyclic change through the events of 
ovulation and menstruation. More recently, McNeilly & Chard (1974) have published 
further detailed data which indicate that there is, in fact, a great deal of variability from one 
woman to another regarding the menstrual pattern of prolactin secretion. In some individual 
women there appears to be little change throughout the cycle while other women have 
been identified clearly by McNeilly and Chard to have the mid cycle peak and luteal phase 
elevations which were published by Robyn et al. (1973). All workers seem to agree that the 
variability which is found in plasma prolactin levels during the luteal phase is much greater 
than during the follicular phase. 
All of  these studies are reported on prolactin levels obtained during the morning hours. The 
circadian rhythm of plasma prolactin is well known and the highest levels occur during the 
late hours of sleep (around 5 a.m.) (Frantz, Habif, Hyman, Suh, Sassin, Zimmerman, Noel 
& Kleinberg, 1973). A more clear picture of the menstrual changes in prolactin secretion 
might well be obtained by sampling during the night. For example, Robyn et al. (1973) 
demonstrated that the mean serum prolactin levels in men and women are almost identical 
at 9 a.m. and at 1 p.m. whereas large differences can be detected, with women having higher 
values, at 1 a.m. and 5 a.m. To summarize: in at least some women the plasma prolactin 
levels which occur during the luteal phase of the cycle are considerably higher than during 
the follicular phase and these high levels are maintained until the onset of menstruation, 
at a time when estrogen and progesterone values are dropping rapidly. 
ACTH and cortisol. Both ACTH and cortisol levels tend to show a cyclic pattern, with 
relatively lower levels during the follicular than during the luteal phase. Both hormones 
show a modest increase at the time of ovulation and a small decrease during the pre- 
menstrual phase (Genazzani, Lemarchand-Beraud, Aubert & Felber, 1975). Once again, 
however, these data are taken from single samples obtained in the morning and they do not 
give any reflection of possible alterations in the circadian secretory pattern. 
Mineralocorticoids. The urinary excretion of aldosterone during the luteal phase is about 
twice that of the follicular phase (Reich, 1962) and this increase is known to be accom- 
panied by similar changes in the secretion rate of aldosterone (Gray, Strausfeld, Wantanabe, 
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Sims & Solomon, 1968). The daily pattern of plasma aldosterone concentrations was 
studied by Katz & Romfh (1972) who demonstrated that the fasting supine plasma aldo- 
sterone levels in normally menstruating women rose to a peak at about the ninth or tenth 
day before menstruation and then dropped rapidly on about the sixth or seventh day before 
menstrual bleeding began. Similar results were reported by Michelakis, Yoshida & Dormois 
(1975). These authors demonstrated also that there were no changes in plasma aldosterone 
levels detected during anovulatory cycles. Schwartz & Abraham (1975) have confirmed that 
the morning plasma aldosterone levels during the follicular phase are considerably lower 
than during the luteal phase in menstruating women. They demonstrated as well that plasma 
corticosterone levels follow a similar pattern. Two patients with menstrual edema had 
particularly high levels of aldosterone and corticosterone. Dexamethasone treatment 
produced at least partial suppression of colticosterone levels in all subjects and suppressed 
also the elevated aldosterone levels in the two women with edema. However, the aldosterone 
levels of normal women were not suppressed by dexamethasone. The same group has also 
shown that plasma levels of desoxycorticosterone are significantly higher in the luteal than 
in the follicular phase of the menstrual cycle (Manlimos, Maroulis & Abraham, 1975). 
Renin--angiotensin system. As mentioned above, Schwartz & Abraham (1975) showed that 
the elevated luteal levels of plasma aldosterone in normal women were not suppressible by 
dexamethasone. In most women during the luteal phase, aldosterone secretion is believed to 
rise as a result of increased activity in the renin-angiotensin system. Stmdsfjord & Aakvaag 
(1970) showed that plasma angiotensin II levels during the luteal phase were almost double 
those during the follicular phase, and they suggested that the sequence of events occurring 
was: increased progesterone secretion leading to sodium loss through the kidneys, leading 
in turn to increased secretion of renin and angiotensin. The angiotensin in turn would lead 
to increased secretion of aldosterone. Subsequently Katz & Romfh (1972) demonstrated 
that plasma renin activity rises in the luteal phase immediately before plasma aldosterone 
levels and that plasma renin activity then falls, with the aldosterone levels decreasing 
shortly afterwards in the late luteal phase (Fig. 2). Michelakis et aL (1975) obtained the 
same results as Katz & Romfh (1972) and they further demonstrated that during anovulatory 
cycles, when progesterone secretion and pregnanediol excretion did not rise during the 

















FIG. 2. Plasma aldosterone and plasma renin activity (PRA) in one woman during a normal cycle. From 
Katz & Romfh (1972). Reproduced by permission of the Editor, Journal of Clinical Endocrinology and 
Metabolism. 
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luteal phase, then no changes occurred in plasma aldosterone levels or plasma renin activity. 
A similar finding for anovulatory cycles was reported by Sundsfjord & Aakvaag (1970). 
Besides this indirect action of progesterone in causing increased renin secretion, estrogens 
interact with the system by inducing the hepatic formation of renin substrate (angio- 
tensinogen) (Laragh, 1974). 
Androgens. The plasma levels of testosterone and androstenedione generally show a 
mid-cycle peak (Judd & Yen, 1973) (Fig. 3). This was confirmed also by Abraham who 
showed in addition that the ovary as well as the adrenal contributes to peripheral levels of 
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FIo. 3. Mean values of LH, FSH, androstenedione and testosterone in 6 women during normal menstrual 
cycles. From Judd & Yen (1973). Reproduced by permission of the Editor, Journal o f  Clinical Endocrinology 
and Metabolism. 
testosterone, dihydrotestosterone and androstenedione (Abraham & Chakmakjian, 1973; 
Abraham, 1974). Plasma androgen levels do not appear to have been studied in women 
with premenstrual dysphoria. This lack is rather surprising in view of the suggested associa- 
tion between testosterone and both sexual drive and aggression (Rose, 1972) and also in 
view of the common exacerbation of acne which occurs with premenstrual dyspboria 
(Sutherland & Stewart, 1965). The mid-cycle peak of circulating androgens corresponds in 
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time with the peak in estrogens and prolactin. It was recently shown that both the nocturnal 
and diurnal secretion of testosterone in males is influenced by concurrent secretion of 
prolactin (Rubin, Gouin, Lubin, Poland & Pirke, 1975; Rubin, Poland & Tower, 1976). 
It would be of interest to document the cyclic changes in testosterone levels in women who 
also experience a luteal elevation of prolactin. 
In summary, phasic changes in the secretion of gonadatropins, prolactin, progesterone, 
estrogens, androgens and mineralocorticoids are known to occur during the menstrual 
cycle. Changes in the renin-angiotensin system appear to precede alterations in aldosterone 
secretion and to be determined by the secretion of progesterone from a functioning corpus 
luteum. During the late luteal phase of the cycle the levels of renin, angiotensin, progesterone, 
estrogen and androgens drop sharply beginning about 6 days before menstruation. In at least 
some women the levels of prolactin remain elevated and do not drop until the onset of 
menstruation. 
2. Estrogen-progesterone imbalance theories 
Most early investigators of premenstrual tension focused naturally enough on the 
relationship between the ovarian hormones and behavioral syndromes. Smith (1975) has 
reviewed these theories. At one time or another, workers have suggested that the behavioral 
changes were caused by (a) a relative deficiency of estrogens; (b) a relative deficiency of 
progesterone; (c) idiosyncratic sensitivity to estrogens or (d) a withdrawal reaction to either 
estrogen or progesterone. No general agreement about these hormone changes has been 
reached and this is reflected by the very large number of suggested treatments. Dalton 
(1964, 1971) has been an enthusiastic advocate of the progesterone deficiency theory and 
has actively promoted the use of progesterone in the treatment of the condition. The pre- 
menstrual syndrome was attributed to 'progesterone withdrawal'; other reports appear to 
support the 'estrogen withdrawal' theory. Laboratory evidence for both these patterns 
has been reported (see Smith, 1975). The confusion and disagreement between these two 
schools may result from variations in the definitions used by different investigators. Dalton 
(1964, 1971) appears to be describing mostly a syndrome of premenstrual irritability and 
hostility, rather than depression as such. Backstrom & Carstensen (1974) presented im- 
pressive evidence for low progesterone levels in women with 'premenstrual anxiety'. 
Cullberg (1972) also concluded that some cases of 'premenstrual irritability' were due to 
estrogen dominance (i.e. a relative lack of progesterone). On the other hand, Smith and his 
associates, who carefully selected a group of women with 'premenstrual depression, as 
opposed to irritability, edema or anxiety' found minimal differences in plasma progesterone 
levels, and no improvement with progesterone injections (Smith, 1975). From reviewing 
these reports it seems possible that premenstrual irritability-anxiety-hostility may be a 
separate condition from premenstrual depression as such. These two conditions could also 
coexist in some women. 
3. Pyridoxine (vitamin B6) deficiency 
A number of workers have speculated that the depressed affect which sometimes accom- 
panies oral contraceptive treatment might be related to a functional deficiency ofpyridoxine, 
and that a similar problem could be the basis for premenstrual dysphoria (Rose, 1969; 
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Winston, 1973; Herzberg, Draper, Johnson & Nicol, 1971). The successful use of pyri- 
doxine to treat premenstrual tension was reported by Winston (1969) and by Baumblatt & 
Winston (1970) but could not be confirmed in a better controlled study by Stokes & Mendels 
(1972). 
4. Renin-angiotensin-aldosterone system 
Janowsky, Berens & Davis (1973) suggested that premenstrual depression might be 
related to activation of the renin-angiotensin-aldosterone system. They studied young 
college women on a metabolic ward and documented changes in 'negative affect', urinary 
sodium and potassium excretion, and body weight. They observed rising levels of negative 
affect until the day of menstruation when the affect scores and body weight dropped drama- 
tically. The urinary potassium/sodium ratios increased until 4 days before menstruation, 
at which time they dropped sharply. On the basis of their data, Janowsky et al. (1973) 
suggested that the negative affect was more closely related in time to electrolyte and water 
retention than to changes in estrogen and progesterone. They suggested that direct actions 
of angiotensin on the nervous system might cause the negative affect. Once again some 
aspects of the diagnostic criteria used in this study are questioned. In this study 'negative 
affect' included depression together with symptoms such as irritability, jitteriness, tension 
and argumentativeness, which may not all belong to the same category. As already men- 
tioned, more recent studies have shown clearly that the activity in the renin-angiotensin- 
aldosterone system in fact drops sharply about 6 days before menstruation occurs. In light 
of this new information it seems unlikely that angiotensin was related to the late luteal 
'negative affect' and fluid retention, which persisted up until the day of menstruation. 
Adamopoulos, Loraine, Lunn, Coppen & Daly (1972) have demonstrated that pre- 
menstrual depression and dysphoria do occur in menstrual cycles which are anovulatory. 
Since changes in the renin-angiotensin-aldosterone system do not occur in such cycles 
(see above) it is unlikely that angiotensin is responsible for the behavioral changes seen at 
this time, as had been suggested by Janowsky et al. (1973). These findings with anovulatory 
cycles also tend to rule out progesterone as the major factor in producing premenstrual 
dysphoria. 
5. Monoamine oxidase activity 
High levels of plasma monoamine oxidase (MAO) activity have been demonstrated in 
premenstrual women (Klaiber, Kobayaski, Broverman & Hall, 1971). These changes in 
plasma MAO activity are paralleled by a premenstrual rise in the enzyme activity in the 
endometrium during the late luteal phase (Grant & Pryse-Davies, 1968). These workers 
also noted that oral contraceptives with a high progestogen content induce major elevations 
in endometrial MAO activity, whereas the more estrogenic compounds do not. Belmaker, 
Murphy, Wyatt & Loriaux (1974) have demonstrated a peak platelet MAO activity during 
the mid-cycle phase and a nadir premenstrually. There were no significant relationships 
between platelet MAO activity and a global scale of menstrual mood variations. These 
results confirm a previous study by Gilmore, Robinson, Nies, Sylvester & Ravaris (1971), 
Low platelet MAO levels were also reported in premenstrual monkeys (Redmond, Murphy, 
Baulu, Ziegler & Lake, 1975). Both Klaiber and Grant have speculated that the progesto- 
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genic stimulation causes generalized changes in MAO activity which could be a factor in 
the occurrence of depression and loss of libido in susceptible women. As yet however, 
there is no direct evidence that these peripheral changes in MAO activity during the cycle 
occur in the human central nervous system. 
REVIEW OF TREATMENTS 
The long list of treatments recommended over the years for the premenstrual syndromes 
illustrates all too clearly the ambiguity and uncertainty in this area. Oral contraceptives, 
synthetic progestogens, progesterone itself, aldosterone antagonists, diuretics, minor 
tranquillizers, lithium, vitamins, psychotherapy and also physical therapy have been 
advocated at one time or another. The outstanding feature of the therapeutic literature in 
premenstrual dysphoria is that all of these treatments have been introduced with enthusiasm 
on the basis of uncontrolled studies but none has survived rigorous testing in controlled 
clinical trials. At the time of writing there is no single treatment which is universally accepted 
as effective. We noted above that much of the difficulty in this area probably results from 
the fact that at least two different subgroups may be included under the general heading 
'premenstrual tension syndrome'. 
Controlled studies 
Cullberg (1972) examined 320 women and claims to have identified a small subgroup of 
patients with premenstrual dysphoria who "were clearly hormone-dependent". Oral 
contraceptives which were highly estrogenic made them worse whereas strongly progesto- 
genie oral contraceptives improved their symptoms. The precise behavioral characteristics 
of this subgroup were not specified clearly. There is a large and somewhat confusing 
literature on the effects of oral contraceptives. Moos (1969a) and also Herzberg et aL (1971) 
found that in general premenstrual symptoms were decreased in women on oral contra- 
ceptives. Nevertheless, there did appear to be a small group who were made worse. Coppen, 
Milne, Outram & Weber (1969) and Jordheim (1972) compared synthetic progestogens to 
diuretics, placebo and a progestogen-diuretic combination. The results of these double-blind 
studies failed to confirm the effectiveness of any of the active agents. 
Dalton (1964, 1971) has been an enthusiastic advocate for the use of intramuscular 
progesterone. Both she and Rees (1953) report that some women improved dramatically with 
progesterone treatments. However, there are no carefully controlled studies from these 
authors to support their claims. In one well-controlled study by Smith (1975) progesterone 
was shown to have no effect in women carefully selected for premenstrual depression with- 
out irritability and hostility. In the same study the aldosterone antagonist, spironolactone, 
was used in another group. The results indicated that there were no cases in which this drug 
was either effective or deleterious. Diuretic agents are at best only adjunctive treatments 
and have not been proven effective in controlled studies (see Smith, 1975). The claims for 
pyridoxine were reviewed briefly in an earlier section. 
Lithium 
Given the cyclic nature of the syndrome and the prominence of affective symptoms, it is 
surprising that so little has beenreported on the effects of lithium on premenstrual dysphoria. 
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Sletten & Gershon (1966) gave 300 mg of lithium carbonate 3 times daily beginning 10 days 
before the expected onset of menstruation and ending with the menstrual flow. Eight 
women with a history of irritability, headaches, explosive emotional outbursts, tension, 
insomnia and depression during the premenstrual period were said to be treated success- 
fully with this regimen for up to 12-18 months. This was an open, uncontrolled study. 
Fries (1969) mentioned that lithium had a good effect in 2 out of 5 women who were 
treated for premenstrual tension. He did not specify the symptomatology or the dosage and 
administration schedule of lithium, stating only that they were treated for more than one 
menstrual cycle. Tupin (1972) mentions one case with premenstrual tension who improved 
partly with lithium therapy. The detailed data were not given. Singer, Cheng & Schou (1974) 
compared lithium with placebo in a double-blind, multiple random cross-over study 
involving 19 outpatients suffering from premenstrual tension. Lithium treatment was given 
throughout the month. The patients had good improvements with both lithium and placebo 
and there were no differences between the two treatments. It is difficult to evaluate the 
significance of this study in view of the fact that 12 of their patients were diagnosed as 
having concomitant other psychiatric conditions (3 affective psychoses, 4 neuroses and 5 
remitted schizophrenics). Mattsson & Von Schoultz (1974), using a cross-over double blind 
design, conducted a well controlled study of lithium treatment. Eighteen women received 
lithium carbonate, 200 mg 4 times daily beginning 14 days before the first day of expected 
menstrual flow. The lithium treatment was compared with 2 other regimens--a diuretic 
(chlorthalidone), and placebo. Each treatment was given over 2 premenstrual periods. Each 
treatment improved the symptoms of premenstrual tension. The rank order of effectiveness 
was placebo first, followed by the diuretic, with lithium least active. A diuretic effect of the 
lithium accompanied improvement in some cases. Once again, in this study, the symptoms 
described involved at least 4 subgroups, i.e. anxiety-tension, depression, irritability and 
feelings of swelling. Horrobin, Manku, Nassar, & Evered (1973) reported on one woman 
with a severe premenstrual edema syndrome. She was given 500 mg lithium carbonate 
daily beginning on the day of elevation of basal body temperature and continuing until 
menstruation occurred. She was reported to be free of edema for 2 complete cycles. This 
patient also experienced severe dysphoria coincident with the premenstrual edema, and her 
psychological symptoms were likewise relieved during her treatment with lithium. After 6 
months, however, the physical and psychological effectiveness of this treament was greatly 
diminished (Horrobin, Mtabaji, Karmali, Manku & Nassar, 1976). 
On the basis of these studies carried out to date, the possible effectiveness of lithium in 
any subgroup with the premenstrual syndrome remains still an open question. 
Bromocriptine 
A very promising new form of treatment for premenstrual symptoms was reported 
recently by Benedek-Jaszmann & Hearn-Sturtevant (1976). They treated a large number of 
women with bromocriptine (2-bromo-a-ergocryptine, CB 154, Sandoz), which is a drug 
that suppresses the secretion of prolactin from the anterior pituitary. In both open and 
double-blind evaluations this drug produced dramatic relief of several types of premenstrual 
symptoms--breast symptoms, edema, weight gain and mood. The frequency and quality of 
virtually complete improvement obtained with bromocriptine were remarkable by com- 
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parison with the other treatments reviewed earlier. Cole, Evered, Horrobin, Manku, 
Mtabaji & Nassar (1975) have obtained similar results in one woman over a period of 2 yr. 
In fact, this is the same woman mentioned previously (Horrobin et al., 1973, 1976) who was 
treated initially with lithium and then switched to bromocriptine. 
Bromocriptine has been shown to be a specific anti-galactic agent in animal studies 
(Billetier & Fluckiger, 1971), in puerperal women (Varga, Lutterbeck, Pryor, Wenner & 
Erb, 1972), in women with galactorrhea and menstrual disturbances (Rolland, Schellekens 
& Lequin, 1974) and in men with galactorrhea and impotence (Besser, Parke & Edwards, 
1972). Recently Rolland and co-workers (Rolland, Lequin, Schellekens & DeJong, 1975a; 
Rolland, DeJong, Schellekens & Lequin, 1975b) have also shown that bromocriptine 
administration during the puerperal period inhibits prolactin secretion and causes an 
immediate restoration of normal ovulatory function with the appearance of regular periods. 
High levels of prolactin are believed to inhibit ovulation (Seppala, Hirvonen, Ranta, 
Virkkunen & Leppaluoto, 1975) and this may account for the fact that many of the patients 
studied by Benedek-Jaszmann & Hearn-Sturtevant (1976) became pregnant while their 
prolactin secretion was inhibited by bromocriptine. If high prolactin levels are involved in 
the etiology of the premenstrual tension syndrome this would also help to explain the high 
incidence of anovulatory cycles noted in such women by Adamopoulos et al. (1972). 
COMMENT 
The pleomorphic nature of premenstrual physiologic and psychologic symptoms has 
defied a convincing psychobiologic explanation. Even the formal nosology of the behavioral 
changes is disputed; recent studies have been cited which either support or reject the idea 
that premenstrual depression is related to the primary affective disorders. Although the 
present reviewers are inclined to agree with Diamond et al. (1976) that there is no such 
specific association, it is still the case that "the phenomenology of premenstrual depression 
has not been studied with the rigor necessary to fit it into the current classification of 
depression" (Smith, 1975). Some of the studies we have reviewed suggest that there are 
several distinct premenstrual behavioral syndromes--depression, elation and hostile 
irritability. While it may be possible to identify subgroups of women with these circum- 
scribed premenstrual syndromes, it nevertheless seems that most women experience some 
combination of these symptoms. Some of the psychoendocrine studies we have discussed 
above suggest that premenstrual irritability may be related to low progesterone levels; this 
factor appears to be less important in the case of premenstrual depression. The more recent 
proposal that premenstrual 'negative affect' is determined by the renin-angiotensin- 
aldosterone system has not been supported by subsequent detailed studies of this system 
during the menstrual cycle. Various other biological theories of the premenstrual syndrome 
have been suggested, but without convincing evidence. 
This underlying difficulty in our clinical and endocrinologic understanding of the pre- 
menstrual syndrome is reflected in the number of suggested treatments: oral contraceptives, 
synthetic progestogens, progesterone, aldosterone antagonists, diuretics, vitamins, minor 
tranquillizers, lithium, psychotherapy and physical therapy. Controlled studies have 
repeatedly failed to confirm the effectiveness of any of these treatments. The possible 
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uti l i ty o f  l i th ium has  no t  yet  been conclusively ruled out, a l though  the avai lable  evidence is 
no t  encouraging.  
By con t ras t  with these previous  t reatments ,  the recent  tr ials  o f  b romocr ip t ine  are  much  
more  promis ing.  This  d rug  is believed to act by suppress ingpro lac t in  secret ion and  appea r s  
to  be effective agains t  bo th  physical  and  behaviora l  p remens t rua l  symptoms .  I f  these 
ini t ia l  repor ts  are  conf i rmed in subsequent  studies, theories a b o u t  the psychob io logy  o f  
p re -mens t rua l  dysphor ia  will need to be revised to  take  into account  the role o f  pro lac t in .  
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